185 related articles for article (PubMed ID: 8589368)
1. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
[TBL] [Abstract][Full Text] [Related]
2. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen.
Jayabose S; Tugal O; Sandoval C; Li K
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):338-40. PubMed ID: 7526722
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
5. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].
Zeidler C; Reiter A; Yakisan E; Koci B; Riehm H; Welte K
Klin Padiatr; 1993; 205(4):264-71. PubMed ID: 7690865
[TBL] [Abstract][Full Text] [Related]
6. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias].
Ueda K; Hanawa Y; Takaku F; Asano S; Tsukimoto I; Tsuchida M; Sato T; Ohira M; Hoshi Y; Nishihira K
Rinsho Ketsueki; 1991 Mar; 32(3):212-20. PubMed ID: 1710294
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis.
Hellmich B; Schnabel A; Gross WL
Arthritis Rheum; 1999 Aug; 42(8):1752-6. PubMed ID: 10446877
[TBL] [Abstract][Full Text] [Related]
9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
10. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
11. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
12. Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy.
Tidow N; Pilz C; Kasper B; Welte K
Stem Cells; 1997; 15 Suppl 1():113-9; discussion 120. PubMed ID: 9368331
[TBL] [Abstract][Full Text] [Related]
13. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia.
Quintas-Cardama A; Kantarjian H; O'Brien S; Garcia-Manero G; Rios MB; Talpaz M; Cortes J
Cancer; 2004 Jun; 100(12):2592-7. PubMed ID: 15197801
[TBL] [Abstract][Full Text] [Related]
15. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
Beaupain B; Leblanc T; Reman O; Hermine O; Vannier JP; Suarez F; Lutz P; Bordigoni P; Jourdain A; Schoenvald M; Ouachee M; François S; Kohser F; Jardin F; Devouassoux G; Bertrand Y; Nove-Josserand R; Donadieu J;
Pediatr Blood Cancer; 2009 Dec; 53(6):1068-73. PubMed ID: 19618456
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic growth factors for the treatment of severe chronic neutropenia.
Dale DC
Stem Cells; 1995 Mar; 13(2):94-100. PubMed ID: 7787781
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
[TBL] [Abstract][Full Text] [Related]
18. [Continuous treatment with colony stimulating factors (G-CSF) for neutropenia associated with type Ib glycogenosis].
de Diego Fernández P; García Fernández JR; Moreno Madrid F; Sánchez Forte M
An Esp Pediatr; 2001 Sep; 55(3):282-4. PubMed ID: 11676908
[TBL] [Abstract][Full Text] [Related]
19. Human granulocyte colony-stimulating factor (rHuG-CSF) for treatment of neutropenia in Shwachman syndrome.
Ventura A; Dragovich D; Luxardo P; Zanazzo G
Haematologica; 1995; 80(3):227-9. PubMed ID: 7545636
[TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
